Clinical Trial
Published on 26 Apr 2024
Transcranial photobiomodulation in children aged 2–6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology
in Experimental Therapeutics
- 21,554 views
- 13 citations





















